By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines that improve patients’ lives.

“Blackstone Life Sciences is focused on bringing important medicines and healthcare technologies to market, often working in partnership with major biopharmaceutical companies to provide them with access capital, scientific expertise and hands-on operational leadership,” “We are excited to collaborate with Novartis to create Anthos Therapeutics, with the goal of delivering important therapies for the high-risk cardiovascular patients who need them”.

Dr. Nicholas Galakatos, Global Head of Blackstone Life Sciences and Chairman of Anthos Therapeutics. (Speaking at launch of Anthos Therapeutics)

Listen to thoughts from Nicholas Galakatos on the potential of Anthos Therapeutics: “Big Bets on Biotech – CNBC Healthy Returns Summit with Nicholas Galakatos”